Patrick Marcellin, Mario Rizzetto. Show Affiliations »
Abstract
Mesh: See more » Antiviral Agents/administration & dosageAntiviral Agents/therapeutic useClinical Trials as TopicDrug Therapy, CombinationGenotypeHepacivirus/classificationHepacivirus/drug effectsHepacivirus/geneticsHepacivirus/physiologyHepatitis C, Chronic/drug therapyHepatitis C, Chronic/virologyHumansInterferon alpha-2Interferon-alpha/therapeutic usePolyethylene Glycols/therapeutic useRecombinant ProteinsRibavirin/administration & dosageRibavirin/therapeutic useTime FactorsTreatment OutcomeViral Load
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2bpeginterferon alfa-2a
Year: 2008 PMID: 18432156
Source DB: PubMed Journal: Antivir Ther ISSN: 1359-6535